RE, Federica
 Distribuzione geografica
Continente #
NA - Nord America 2.752
AS - Asia 1.951
EU - Europa 1.559
SA - Sud America 308
AF - Africa 47
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.632
Nazione #
US - Stati Uniti d'America 2.654
SG - Singapore 829
IT - Italia 657
CN - Cina 418
BR - Brasile 247
DE - Germania 231
HK - Hong Kong 173
BD - Bangladesh 146
VN - Vietnam 124
FR - Francia 117
FI - Finlandia 113
GB - Regno Unito 83
RU - Federazione Russa 65
IN - India 64
UA - Ucraina 63
TR - Turchia 59
CA - Canada 58
CZ - Repubblica Ceca 33
IE - Irlanda 33
NL - Olanda 30
PL - Polonia 26
MX - Messico 24
IQ - Iraq 23
SE - Svezia 22
ZA - Sudafrica 21
AR - Argentina 20
JP - Giappone 20
ES - Italia 18
AU - Australia 13
DK - Danimarca 13
ID - Indonesia 13
AT - Austria 12
BE - Belgio 12
EC - Ecuador 11
TH - Thailandia 10
LT - Lituania 9
MA - Marocco 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
PY - Paraguay 7
UZ - Uzbekistan 7
MY - Malesia 6
EG - Egitto 5
GR - Grecia 5
JO - Giordania 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
CH - Svizzera 4
CO - Colombia 4
IR - Iran 4
NP - Nepal 4
PH - Filippine 4
CL - Cile 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KG - Kirghizistan 3
PA - Panama 3
PE - Perù 3
PK - Pakistan 3
SN - Senegal 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
IL - Israele 2
KR - Corea 2
LB - Libano 2
LK - Sri Lanka 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CG - Congo 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 6.632
Città #
Singapore 445
Ashburn 323
San Jose 257
Hong Kong 171
Chandler 167
New York 152
Brescia 147
Fairfield 134
Munich 110
Los Angeles 105
Beijing 102
Dallas 92
The Dalles 77
Seattle 70
Helsinki 64
Milan 64
Ann Arbor 54
Woodbridge 54
Lauterbourg 53
Wilmington 48
Des Moines 47
Houston 47
Jacksonville 47
Princeton 45
Council Bluffs 43
Istanbul 41
Cambridge 39
Ho Chi Minh City 39
Shanghai 38
Boardman 37
Turku 35
Dublin 32
Rome 32
Hanoi 30
Santa Clara 29
São Paulo 29
Chicago 26
Brno 25
San Francisco 25
Frankfurt am Main 24
Redondo Beach 24
Buffalo 22
Toronto 20
Moscow 19
Pune 19
Orem 18
Tokyo 18
Boston 15
Montreal 15
Warsaw 15
Johannesburg 14
Turin 14
Chennai 13
San Diego 13
Brussels 12
Denver 12
Genoa 12
Helsingør 12
London 12
Atlanta 11
Baghdad 11
Brooklyn 11
Nuremberg 11
Poplar 11
Lappeenranta 10
Romola 10
Charlotte 9
Florence 9
Mexico City 9
Wroclaw 9
Adelaide 8
Amsterdam 8
Düsseldorf 8
Manchester 8
Phoenix 8
Stockholm 8
Tianjin 8
Barlassina 7
Bologna 7
Bosio 7
Bovegno 7
Dearborn 7
Gorlago 7
Olomouc 7
Paris 7
Tashkent 7
Brasília 6
Curitiba 6
Da Nang 6
Haiphong 6
Jakarta 6
Pescara 6
Verona 6
Amman 5
Bangkok 5
Bergamo 5
Biên Hòa 5
Buenos Aires 5
Calgary 5
Campinas 5
Totale 4.005
Nome #
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 210
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 210
Rational Design and Development of Anisotropic and Mechanically Strong Gelatin-Based Stress Relaxing Hydrogels for Osteogenic/Chondrogenic Differentiation 186
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 186
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 170
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 168
Chitosan-Hydrogel Polymeric Scaffold Acts as an Independent Primary Inducer of Osteogenic Differentiation in Human Mesenchymal Stromal Cells 164
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 158
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 154
Bioengineered scaffolding for mandibular reconstruction: a preclinical, xenograft animal study 154
Development of a cell culture model based on biocompatible polymeric scaffolds engineered with human Mesenchymal Stromal Cells (MSCs) for cartilage and bone regenerative therapy 151
3D-MAPPING OF MESENCHYMAL STEM CELLS GROWTH ON BIOENGINEERED SCAFFOLDS FOR MAXILLOFACIAL SKELETON REGENERATION: A PRECLINICAL, IN VITRO STUDY 148
Impedance-based monitoring of mesenchymal stromal cell three-dimensional proliferation using aerosol jet printed sensors: A tissue engineering application 147
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 145
Development of a Preclinical Double Model of Mandibular Irradiated Bone and Osteoradionecrosis in New Zealand Rabbits 145
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 141
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 136
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial 135
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 131
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 130
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 129
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 128
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 128
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 124
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection 121
Mineralization of 3D Osteogenic Model Based on Gelatin-Dextran Hybrid Hydrogel Scaffold Bioengineered with Mesenchymal Stromal Cells: A Multiparametric Evaluation 121
Chitosan-based scaffold counteracts hypertrophic and fibrotic markers in chondrogenic differentiated mesenchymal stromal cells 117
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 113
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol) 111
Bone Regeneration Using Mesenchymal Stromal Cells and Biocompatible Scaffolds: A Concise Review of the Current Clinical Trials 110
Comparative Mutational Profiling of Hematopoietic Progenitor Cells and Circulating Endothelial Cells (CECs) in Patients with Primary Myelofibrosis 110
Potentiality of Bone Marrow-Derived Mesenchymal Stromal Cells (BM-MSCs) to Differentiate into the Osteogenic Lineage in in Vitro Model of Tissue Regeneration 107
Correlation between BCR::ABL1 Transcript LEVEL in Circulating Extracellular Vesicles and BOTH the Molecular Response and the Ongoing Therapy: A Study on Adult CML Patients 106
Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients 105
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 104
Successful CAR-T cell therapy in a refractory MCL patient with bacterial, fungal and COVID-19 infection: a case report 100
Hybrid Core-Shell Polymer Scaffold for Bone Tissue Regeneration 98
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation 97
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 97
Immune Reconstitution after Allogenic Stem Cell Transplantation in Patients with Myelofibrosis 95
Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French–Italian Experience of 134 Patients 93
Hydrogel-chitosan and polylactic acid-polycaprolactone bioengineered scaffolds for reconstruction of mandibular defects: a preclinical in vivo study with assessment of translationally relevant aspects 93
PB1959: BCR::ABL1 TRANSCRIPT IN SMALL EXTRACELLULAR VESICLES ISOLATED IN ADULT CHRONIC MYELOID LEUKEMIA PATIENTS CORRELATES WITH MOLECULAR RESPONSE LEVEL AND THE ONGOING THERAPY 93
In Vitro Biocompatibility Assessment of Bioengineered PLA-Hydrogel Core–Shell Scaffolds with Mesenchymal Stromal Cells for Bone Regeneration 89
New Poly(lactic acid)-Hydrogel Core-Shell Scaffolds Highly Support MSCs' Viability, Proliferation and Osteogenic Differentiation 86
Bone regeneration improves with mesenchymal stem cell derived extracellular vesicles (Evs) combined with scaffolds: A systematic review 85
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR) 82
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation (Bone Marrow Transplantation, (2023), 10.1038/s41409-023-02124-y) 78
Intensive Chemotherapy Versus Venetoclax-Based Regimens in Elderly Patients with Acute Myeloid Leukemia: Is the Chemotherapy Era Ending? 76
Gelatin-Based Scaffolds with Carrageenan and Chitosan for Soft Tissue Regeneration 72
Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular Vesicles 71
Digital PCR as a New Method for Minimal Residual Disease Monitoring and Treatment Free Remission Management in Chronic Myeloid Leukemia Patients: Is It Reliable? 62
Twenty years of evolution of CML therapy: how the treatment goal is moving from disease to patient 53
Polysaccharides on gelatin-based hydrogels differently affect chondrogenic differentiation of human mesenchymal stromal cells 50
Stimulated CAR-T cells from non-Hodgkin lymphomas patients engage and activate monocytes via extracellular vesicles 34
Beyond presence: Clinical relevance of FLT3-ITD length and location in Acute Myeloid Leukemia (AML) 33
P022 | Fourier-transform infrared spectroscopy analysis of plasma-derived extracellular vesicles as a tool to detect TKI-related toxicity in chronic myeloid leukemia patients: a preliminary study 31
P046 | Beyond the mutation: prognostic role of FLT3-ITD length and genomic context in acute myeloid leukemia 30
CO41 | Monocyte activation by CAR-T cells: role of extracellular vesicles and secretome in immune modulation 30
P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR 23
Design and Characterization of a 3D In Vitro Model of Chitosan/Glycerol-Based Hydrogels With Human Mesenchymal Stromal Cells for Skin Wound Healing 21
CO43 | Fourier-transform infrared spectroscopy of plasma as a liquid biopsy for monitoring acute myeloid leukemia and extramedullary relapse following allo-HSCT 21
Current Biomaterials and Strategies in Tissue Engineering for Wound Healing 13
Effects of Physical Stimulation and Bioactive Agents in Bone Regenerative Medicine: Recent Advances and Synergistic Approaches 10
NGS-Driven Digital PCR for Personalized and Accurate Measurable Residual Disease Assessment in Acute Myeloid Leukemia 8
Totale 6.727
Categoria #
all - tutte 32.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022272 28 11 12 24 13 19 13 19 15 38 28 52
2022/2023438 47 31 15 50 39 74 4 46 65 9 25 33
2023/2024579 22 15 44 28 51 139 31 31 69 16 16 117
2024/20251.551 40 49 26 164 116 86 130 67 257 126 276 214
2025/20263.245 242 274 187 378 340 264 439 170 233 341 200 177
Totale 6.727